Paediatric Liver Transplant Programme Wits Donald Gordon Medical Centre

Size: px
Start display at page:

Download "Paediatric Liver Transplant Programme Wits Donald Gordon Medical Centre"

Transcription

1 Paediatric Liver Transplant Programme Wits Donald Gordon Medical Centre J Loveland, J Botha, R Britz, B Strobele, S Rambarran, A Terblanche, C Kock, P Walabh, M Beretta, M Duncan et al

2

3 1817 reveal the presence of 1 st clear English language reference to BA John Burns Regius Professor of Surgery University of Glasgow Burns J. Principles of Midwifery, including the diseases of women and children 1817:602

4 Looking at the problem of biliary atresia from the vantage point of 30 years experience with the lesion, we can say with certainty that the jaundiced baby who has had no extrahepatic bile duct has been the most disappointing patient for the surgeon in the whole realm of lesions theoretically correctable by a surgical procedure.

5

6 Scientific fields progress in a linear and continuous way Laborious grind and dog work Predictable solving of puzzles that are left open in a current field of knowledge..a pleasant way to keep busy when one is not up to useful work Coran Hind Grosfeld Millar Davenport Puri Loveland

7 The Structure of Scientific Revolutions Normal science with a paradigm and a dedication to solving puzzles; followed by serious anomalies, which lead to a crisis; and finally resolution of the crisis by a new paradigm Paradigm shift in treatment and outcomes Ian Hacking Introductory Essay The Structure of Scientific Revolutions

8

9 Kasai et al. Journal of Paediatric Surgery (6)

10 Alluded to ductal diameter of 150 microns as potentially prognostic for drainage 10 of 14 with ducts > 200μ drained Only 1 of 13 < 150μ Size may be of great significance All cured cases surgery before 4 months of age Not a few cases. Might be curable if portoenterostomy carried out before 4 months of age, preferably within 3 months after birth Kasai et al. Journal of Paediatric Surgery (6)

11 The First 1963 C Henry Kempe presented Bennie Solis to Starzl Department of Paediatrics University of Colorado Infectious Diseases Specialist Coined term Battered Child Syndrome Defender of children Starzl suggested transplant Kempe agreed 1981 when moved to Pittsburgh, firmly supported moving program forward The Puzzle People

12 Complementary role of KP and LT now accepted standard treatment BA Vacanti et al. Journal of Pediatric Surgery : Sequential employment significantly improved prognosis Otte et al. Hepatology (Suppl):41S-48S

13

14

15

16

17 Loveland et al. S Afr Med J 2012;102(4):

18

19 SO WHERE ARE WE TODAY 134 transplants 8 re-transplants 36.57% LDLT (49/134) 34.33% whole (46/134) 18.66% splits (25/134) 10.45% Reduced size (14/134) 12 fulminant hepatic failure 12 CLKT

20 (1st 6m) Number of transplants UNIT GROWTH Year of transplant

21 DEMOGRAPHIC OF AETIOLOGY % of recpients with chronic liver failure (n=117) biliary atresia budd chiari - veno-occlusive disease oxalisis auto-immune disease chronic rejection of liver graft alpha-1 antitrypsin deficiency alagille syndrome (biliary hypoplasia) wilson's disease polycystic kidney disease and hepatic fibrosis biliary agenesis hepatoblastoma hepatocellular carcinoma cryptogenic maple syrup urine disease PFIC - progressive familial intrahepatic cholestasis other

22 % of recipients (n=115) IMMUNOSUPPRESSION steroids tacrolimus MMF other Immunosuppression at time of transplant

23 GRAFT UTILIZATION Entire Series 134 Era 1 31 Era Whole Grafts (58%) 28 (27.18%) Reduced Size Grafts (32%) 4 (3.88%) Split Grafts 25 3 (10%) 22 (21.6%) Living Donor Grafts (47.57%)

24 GRAFT TYPE BY ERA Whole Reduced Split Era 1: Era 2: Present LDLT Loveland et al. S Afr Med J (11)

25 RECIPIENT AGE

26 Entire Series Era 1 Era 2 Age Range (months) Mean Age Median Age Weight Range (kilograms) Mean Weight Median Weight Loveland et al. S Afr Med J (11)

27 RECIPIENT WEIGHT

28 Entire Series Era 1 Era 2 Age Range (months) Mean Age Median Age Weight Range (kilograms) Mean Weight Median Weight Loveland et al. S Afr Med J (11)

29 Patient Survival Percent survival Time

30 HEPATIC ARTERY THORMBOSIS 4.5% incidence (6/134) 1 Reduced = HAT Day 1 = Died before ReTx 1 Whole = ReTx = Died 1 Whole = Revised D1 = NAD 1 Whole = HAT Day 9 = ReTx Day 22 = NAD 1 Split = HAT Day 10 = ReTx Day 13 = Died 1 Whole = HAT Day 21 = Good function to date 1 Whole = Rupture D11 = Revised

31 VASCULAR COMPLICATIONS 7 PVT and 1 PVS 1 PVT revised with venous interposition 1 PVS required angioplasty and stent 1 PVT required splenorenal shunt Another planned 2 patients venoplasty caval anastomosis

32 BILIARY COMPLICATIONS Increased incidence after split and LDLT Cut surface leaks Long term increase in strictures Ischaemia Attention to detail: LDLT harvest Back table split Biliary reconstruction during implant Meticulous arterial reconstruction

33 LARGE FOR SIZE SYNDROME

34 IMPACT OF LDLT Access greater organ pool Significant ethical issues Benefits Decreasing waiting list death elective transplant Well matched organ may lead to better long-term graft and patient survival Donor operation places well individual at risk: morbidity overall average 35% Decision made without coercion Psychosocial evaluation Anatomical assessment

35 OF SIGNIFICANCE.

36 % of patients aged <=5y THE IMPACT OF Weight Height MUAC

37 ANOTHER SIGNIFICANT HAZARD 3.5 (95% CI ) for patient survival 3.2 (95% CI ) for liver graft survival

38 Number of infections NOSOCOMIAL INFECTION % % 7.1% 0 Bacterial Viral Fungal / yeast

39 INTERVENTION BILIARY ATRESIA Identification Early referral Surgery Centralization Follow up Early referral Transplant assessment

40

41

42 INTERVENTION TRANSPLANT Nutritional support Pre-transplant Infection control Venous access and care Antibiotic stewardship Long Term outcomes Immunosuppression

43

Living Donor Liver Transplantation Wits Donald Gordon Medical Centre

Living Donor Liver Transplantation Wits Donald Gordon Medical Centre Living Donor Liver Transplantation Wits Donald Gordon Medical Centre J Loveland, J Botha, R Britz, B Strobele, A Mahomed, B Bobat, S Rambarran, F van der Schyff et al The First 1963 C Henry Kempe presented

More information

Outcomes of Liver Transplant for Biliary Atresia: A Ten Year Single Centre Experience

Outcomes of Liver Transplant for Biliary Atresia: A Ten Year Single Centre Experience Outcomes of Liver Transplant for Biliary Atresia: A Ten Year Single Centre Experience Dr Yentl van Heerden; Dr Andrew Grieve, Professor Jerome Loveland For Paediatric Hepatobiliary and Liver Transplant

More information

Transplant Hepatology

Transplant Hepatology Transplant Hepatology Certification Examination Blueprint Purpose of the exam The exam is designed to evaluate the knowledge, diagnostic reasoning, and clinical judgment skills expected of the certified

More information

Experience in 1,000 Liver Transplants Under Cyclosporine-Steroid Therapy: A Survival Report

Experience in 1,000 Liver Transplants Under Cyclosporine-Steroid Therapy: A Survival Report Experience in 1,000 Liver Transplants Under Cyclosporine-Steroid Therapy: A Survival Report S. watsuki. T.E. Starzl, S. Todo, R.D. Gordon, C.O. Esquivel, A.G. Tzakis, L. Makowka, J.W. Marsh, B. Koneru,

More information

Liver Transplantation in Children: Techniques and What the Surgeon Wants to Know from Imaging

Liver Transplantation in Children: Techniques and What the Surgeon Wants to Know from Imaging Liver Transplantation in Children: Techniques and What the Surgeon Wants to Know from Imaging Jaimie D. Nathan, MD Associate Professor of Surgery and Pediatrics Associate Surgical Director, Liver Transplant

More information

Liver transplant for biliary atresia

Liver transplant for biliary atresia Jean de Ville de Goyet ISMETT Director of the Department for the Treatment and Study of Pediatric Abdominal Diseases and Abdominal Transplantation The first human liver transplant was performed on a pediatric

More information

Current Management of Biliary Atresia. Janeen Jordan, MD PGY5 Surgery Grand Rounds November 19, 2007

Current Management of Biliary Atresia. Janeen Jordan, MD PGY5 Surgery Grand Rounds November 19, 2007 Current Management of Biliary Atresia Janeen Jordan, MD PGY5 Surgery Grand Rounds November 19, 2007 Overview Etiology and diagnosis Work-up and management History of Kasai Portoenterostomy Studies Advances

More information

CAPGAN th Scientific Meeting of Commonwealth Association of Paediatric, Gastroenterology and Nutrition 2-4 October 2015 : New Delhi, India

CAPGAN th Scientific Meeting of Commonwealth Association of Paediatric, Gastroenterology and Nutrition 2-4 October 2015 : New Delhi, India CAPGAN2015 14 th Scientific Meeting of Commonwealth Association of Paediatric, Gastroenterology and Nutrition 2-4 October 2015 : New Delhi, India ABSTRACT FORM Abstract Category: Oral Poster 1. GASTROENTEROLOGY

More information

Cystic Biliary Atresia: Why Is It Important to Distinguish this from Congenital Choledochal Cyst?

Cystic Biliary Atresia: Why Is It Important to Distinguish this from Congenital Choledochal Cyst? Bahrain Medical Bulletin, Vol. 36, No. 2, June 2014 Cystic Biliary Atresia: Why Is It Important to Distinguish this from Congenital Choledochal Cyst? Hussein Ahmed Mohammed Hamdy, MRCSEd, FEBPS* Hind Mustafa

More information

Liver Transplantation

Liver Transplantation 1 Liver Transplantation Department of Surgery Yonsei University Wonju College of Medicine Kim Myoung Soo M.D. ysms91@wonju.yonsei.ac.kr http://gs.yonsei.ac.kr History Development of Liver transplantation

More information

Ontario s Adult Referral and Listing Criteria for Liver Transplantation

Ontario s Adult Referral and Listing Criteria for Liver Transplantation Ontario s Adult Referral and Listing Criteria for Liver Transplantation Version 3.0 Trillium Gift of Life Network Ontario s Adult Referral & Listing Criteria for Liver Transplantation PATIENT REFERRAL

More information

Live Donor Liver Transplantation: A Life Saving Option for End Stage Liver Disease

Live Donor Liver Transplantation: A Life Saving Option for End Stage Liver Disease Live Donor Liver Transplantation: A Life Saving Option for End Stage Liver Disease Abhi Humar, MD Clinical Director, Thomas E. Starzl Transplantation Institute 1 PITTSBURGH THE BIRTHPLACE OF LIVER TRANSPLANTATION

More information

LIVER TRANSPLANTATION

LIVER TRANSPLANTATION LIVER TRANSPLANTATION Selection 0 / Patients and Results Late Mortality and Morbidity After Liver Transplantation S. Iatsuki. T.E. Starzl. R.D. Gordon, C.O. Esquivel. S. Todo, A.G. Tzakis, L. Makoka. J.W.

More information

Biliary Anatomy in Living-related Liver Transplantation

Biliary Anatomy in Living-related Liver Transplantation The 5th IHPBA Congress - Istanbul Biliary Anatomy in Living-related Liver Transplantation biliary trees hilar plate Assessment for Vascular Anatomy 1. 3DCT portal vein hepatic vein hepatic artery 2. No

More information

Living Donor Liver Transplantation NATCO Introductory Course

Living Donor Liver Transplantation NATCO Introductory Course Living Donor Liver Transplantation NATCO Introductory Course Patricia Harren, RN, ANP, MSN, PNP, CCTC New York Presbyterian Medical Center Center for Liver Disease & Transplant New York, NY Living Donor

More information

Liver Transplantation for Biliary Atresia: 19-Year, Single-Center Experience

Liver Transplantation for Biliary Atresia: 19-Year, Single-Center Experience Liver Transplantation for Biliary Atresia: 19-Year, Single-Center Experience L Thomas Chin 1, Anthony M D Alessandro 1, Stuart J Knechtle 1, Luis A Fernandez 1, Glen Leverson 1, Robert H Judd 2, Elizabeth

More information

EVALUATION & LISTING. Your Child s Liver Transplant Evaluation. What is the Liver?

EVALUATION & LISTING. Your Child s Liver Transplant Evaluation. What is the Liver? EVALUATION & LISTING Your Child s Liver Transplant Evaluation The University of Michigan is a national leader in liver transplantation, as well as the surgical and medical management of patients with liver

More information

Clinical Policy: Pediatric Liver Transplant

Clinical Policy: Pediatric Liver Transplant Clinical Policy: Reference Number: CP.MP.120 Last Review Date: 04/18 Coding Implications Revision Log See Important Reminder at the end of this policy for important regulatory and legal information. Description

More information

Overall Goals and Objectives for Transplant Hepatology EPAs:

Overall Goals and Objectives for Transplant Hepatology EPAs: Overall Goals and Objectives for Transplant Hepatology EPAs: 1. DIAGNOSTIC LIST During the one-year Advanced Pediatric Transplant Hepatology Program, fellows are expected to develop comprehensive skills

More information

Post-operative complications following hepatobiliary surgery: imaging findings and current radiological treatment options

Post-operative complications following hepatobiliary surgery: imaging findings and current radiological treatment options Post-operative complications following hepatobiliary surgery: imaging findings and current radiological treatment options Poster No.: C-1501 Congress: ECR 2015 Type: Educational Exhibit Authors: A. Hadjivassiliou,

More information

Biliary Atresia. Karen F. Murray, MD Professor of Pediatrics Director, Hepatobiliary Program Seattle Children s

Biliary Atresia. Karen F. Murray, MD Professor of Pediatrics Director, Hepatobiliary Program Seattle Children s Biliary Atresia Karen F. Murray, MD Professor of Pediatrics Director, Hepatobiliary Program Seattle Children s Biliary Atresia Incidence: 1/8,000-15,000 live births Girls > boys 1.5:1 The most common cause

More information

BILIARY ATRESIA. What is biliary atresia?

BILIARY ATRESIA. What is biliary atresia? The Childhood Liver Disease Research Network strives to provide information and support to individuals and families affected by liver disease through its many research programs. BILIARY ATRESIA What is

More information

HEALTH SERVICES POLICY & PROCEDURE MANUAL

HEALTH SERVICES POLICY & PROCEDURE MANUAL PAGE 1 of 6 PURPOSE To establish basic understanding of indications and contraindications for transplantation of various organs. POLICY The N.C. Department of Correction, Division of Prisons, Health Services

More information

Liver Transplant: What s Different? Brian Lin, MD, FACEP Emergency Medicine, Kaiser Permanente, San Francisco UCSF Clinical Assistant Professor

Liver Transplant: What s Different? Brian Lin, MD, FACEP Emergency Medicine, Kaiser Permanente, San Francisco UCSF Clinical Assistant Professor Liver Transplant: What s Different? Brian Lin, MD, FACEP Emergency Medicine, Kaiser Permanente, San Francisco UCSF Clinical Assistant Professor No Disclosures. Background 45 years 1998-2008: 90,830 transplants

More information

Approach to a case of Neonatal Cholestasis

Approach to a case of Neonatal Cholestasis Approach to a case of Neonatal Cholestasis Ira Shah (Co-Incharge, Consultant Pediatrician, Pediatric Liver Clinic) Gunjan Narkhede (Resident in Pediatric Liver Clinic) Pediatric Hepatobiliary Clinic, B.J.Wadia

More information

National Center for Child Health and Development Organ Transplantation Center

National Center for Child Health and Development Organ Transplantation Center National Center for Child Health and Development Organ Transplantation Center A t the division of transplantation center in NCCHD, we have a mission to save children s life who have been suffered from

More information

The Endoscopic Management of PSC

The Endoscopic Management of PSC The Endoscopic Management of PSC Raj J. Shah, M.D. Associate Professor of Medicine Director, Pancreaticobiliary Endoscopy Services University of Colorado at Denver and the Health Sciences Center Why did

More information

Home Intravenous Antibiotic Treatment for Intractable Cholangitis in Biliary Atresia

Home Intravenous Antibiotic Treatment for Intractable Cholangitis in Biliary Atresia Home Intravenous Antibiotic Treatment for Intractable Cholangitis in Biliary Atresia Hye Kyung Chang, Jung-Tak Oh, Seung Hoon Choi, Seok Joo Han Division of Pediatric Surgery, Department of Surgery, Yonsei

More information

Information for patients (and their families) waiting for liver transplantation

Information for patients (and their families) waiting for liver transplantation Information for patients (and their families) waiting for liver transplantation Waiting list? What is liver transplant? Postoperative conditions? Ver.: 5/2017 1 What is a liver transplant? Liver transplantation

More information

Biliary Atresia. Greg Tiao, MD. 3 rd Annual Pediatric Surgery Update Course GlobalCastMD

Biliary Atresia. Greg Tiao, MD. 3 rd Annual Pediatric Surgery Update Course GlobalCastMD Biliary Atresia Greg Tiao, MD GlobalCastMD 3 rd Annual Pediatric Surgery Update Course 2015 Case Pediatrician calls you about a 60 day old full term male who is otherwise healthy but is noted to have persistent

More information

Prolonged Neonatal Jaundice

Prolonged Neonatal Jaundice Prolonged Neonatal Jaundice Ahmed Laving KPA Annual Scientific Conference 2018 Prolonged Jaundice? >6 months >3 months >2 weeks >4 weeks Prolonged Jaundice? >6 months >3 months >2 weeks >4 weeks Case Presentation

More information

Extrahepatic Biliary

Extrahepatic Biliary Extrahepatic Biliary Atresia Editor FREDRIC DAUM Associate Editor STANLEY E. FISHER Cornell University Medical College New York, New York North Shore University Hospital Manhasset, New York Copyright 198

More information

PEDIATRIC LIVER TRANSPLANTATION: INDICATIONS AND TECHNICAL PROCEDURES

PEDIATRIC LIVER TRANSPLANTATION: INDICATIONS AND TECHNICAL PROCEDURES Annals of Academy of Romanian Scientists Online edition Series: Medical Sciences ISSN 2285-4150 Volume 1, Number 1/2010 41 PEDIATRIC LIVER TRANSPLANTATION: INDICATIONS AND TECHNICAL PROCEDURES Irinel POPESCU

More information

Informed Consent for Liver Transplant Patients

Informed Consent for Liver Transplant Patients Informed Consent for Liver Transplant Patients Evaluation Process You will be evaluated with consultations, lab tests and various procedures to determine the medical appropriateness of liver transplant.

More information

THE NORDIC LIVER TRANSPLANT REGISTRY ANNUAL REPORT Report prepared by Kristian Bjøro

THE NORDIC LIVER TRANSPLANT REGISTRY ANNUAL REPORT Report prepared by Kristian Bjøro THE NORDIC LIVER TRANSPLANT REGISTRY ANNUAL REPORT 2 Report prepared by Kristian Bjøro March 21 1 Nordic liver transplant registry - 2 As of December 31.2 the registry comprised data on 2167 patients of

More information

ASSESSMENT AND MANAGEMENT OF POTENTIAL LIVER TRANSPLANT CANDIDATES

ASSESSMENT AND MANAGEMENT OF POTENTIAL LIVER TRANSPLANT CANDIDATES ASSESSMENT AND MANAGEMENT OF POTENTIAL LIVER TRANSPLANT CANDIDATES James YY Fung MBChB, MD, FRACP, FHKCP, FHKAM Consultant & Hon. Assoc. Professor Liver Transplant Center Department of Surgery, Queen Mary

More information

Liver Transplantation

Liver Transplantation Liver transplantation has revolutionized the care of patients with end-stage liver disease. Liver transplantation is indicated for acute or chronic liver failure from any cause. Because there are no randomized

More information

LEE AND OTHERS Annual LDLT (n) year Total Adult-to-adult Paedi

LEE AND OTHERS Annual LDLT (n) year Total Adult-to-adult Paedi ADULT-TO-ADULT LIVING DONOR LIVER TRANSPLANTATION Asian Journal of Surgery Excerpta Medica Asia Ltd Adult-to-Adult Living Donor Liver Transplantation at the Asan Medical Center, Korea S.G. Lee, 1 K.M.

More information

6 th August 2018 Day 1 - Gallbladder & Bile duct Topic

6 th August 2018 Day 1 - Gallbladder & Bile duct Topic Venue: Sterling Hospital Auditorium, Sterling Hospitals, Gurukul Road Ahmedabad, Gujarat 6 th August 2018 Day 1 - Gallbladder & Bile duct Registration(8:00am-8:15am) Inauguration(8:15am-8:30am) Welcome

More information

National liver offering scheme

National liver offering scheme 1 National liver offering scheme Outline 1 Hub Specialist Nurse Organ Donation (SNOD) registers donor with Operations 2 matching Hub Operations initiates the run 3 Hub Matching run offering list printed

More information

Alpha-1 Antitrypsin Deficiency: Liver Disease

Alpha-1 Antitrypsin Deficiency: Liver Disease Alpha-1 Antitrypsin Deficiency: Liver Disease Who is at risk to develop Alpha-1 liver disease? Alpha-1 liver disease may affect children and adults who have abnormal Alpha-1 antitrypsin genes. Keys to

More information

Can Universal Screening for rare conditions ever be cost-effective? The case of Newborn Screening for Biliary Atresia

Can Universal Screening for rare conditions ever be cost-effective? The case of Newborn Screening for Biliary Atresia Can Universal Screening for rare conditions ever be cost-effective? The case of Newborn Screening for Biliary Atresia Lisa Masucci 1, Stirling Bryan 1, Janusz A. Kaczorowski 3, Jean-Paul Collet 2, Richard

More information

Solid organ transplantation is a widely recognized treatment for end-stage organ failure

Solid organ transplantation is a widely recognized treatment for end-stage organ failure Basic information Solid organ transplantation is a widely recognized treatment for end-stage organ failure Children account for 5-10% of recipients of solid organ transplants History Pediatric transplant

More information

Victorian Liver Transplant Unit. Annual Report Page 1

Victorian Liver Transplant Unit. Annual Report Page 1 Victorian Liver Transplant Unit Annual Report 2017-2018 Page 1 Contents Preface... 3 Report Purpose... 3 2017/18 Summary... 4 Total Transplant Activity... 5 2017/18 Activity Summary... 5 2017/18 Transplant

More information

Pediatric Kidney Transplantation

Pediatric Kidney Transplantation Pediatric Kidney Transplantation Vikas Dharnidharka, MD, MPH Associate Professor Division of Pediatric Nephrology Conflict of Interest Disclosure Vikas Dharnidharka, MD, MPH Employer: University of Florida

More information

Hepatic Artery Reconstruction in Living Donor Liver Transplant Experience at King Hussein Medical Center

Hepatic Artery Reconstruction in Living Donor Liver Transplant Experience at King Hussein Medical Center Hepatic Artery Reconstruction in Living Donor Liver Transplant Experience at King Hussein Medical Center Khaldoun J. Haddadin MD FRCS (Eng)*, Nasser Q. Ahmad MD MRCSI*, Abdelhamid M. Aladwan MD ** ABSTRACT

More information

Overview Increasing organ donation (heart-beating donation Use of marginal grafts (quality) Cadaveric non-heart-beating donation Splitting Living dona

Overview Increasing organ donation (heart-beating donation Use of marginal grafts (quality) Cadaveric non-heart-beating donation Splitting Living dona Increasing the organ supply Mr. Nigel Heaton Overview Increasing organ donation (heart-beating donation Use of marginal grafts (quality) Cadaveric non-heart-beating donation Splitting Living donation Domino

More information

Pediatric Liver Transplantation Outcomes in Korea

Pediatric Liver Transplantation Outcomes in Korea ORIGINAL ARTICLE Cell Therapy & Organ Transplantation http://dx.doi.org/6/jkms.8..4 J Korean Med Sci 0; 8: 4-47 Pediatric Liver Transplantation Outcomes in Korea Jong Man Kim,, * Kyung Mo Kim,, * Nam-Joon

More information

Current status of hepatic surgery in Korea

Current status of hepatic surgery in Korea Korean J Hepatol. 2009 Dec; 15(Suppl 6):S60 - S64. DOI: 10.3350/kjhep.2009.15.S6.S60 Current status of hepatic surgery in Korea Kyung Sik Kim Department of Surgery, Severance Hospital, Yonsei University

More information

Nutritional Issues in Cholestatic Disease

Nutritional Issues in Cholestatic Disease THE HOSPITAL FOR SICK CHILDREN Nutritional Issues in Cholestatic Disease NASPGHAN-CPNP Joint Session Binita M. Kamath, MBBChir MRCP MTR Associate Professor Division of Gastroenterology, Hepatology and

More information

Corporate Medical Policy Liver Transplant

Corporate Medical Policy Liver Transplant Corporate Medical Policy Liver Transplant File Name: Origination: Last CAP Review: Next CAP Review: Last Review: liver_transplant 12/1995 5/2017 5/2018 5/2017 Description of Procedure or Service Liver

More information

Abdominal Pain and Abnormal Liver Tests After Orthotopic Liver Transplantation

Abdominal Pain and Abnormal Liver Tests After Orthotopic Liver Transplantation Abdominal Pain and Abnormal Liver Tests After Orthotopic Liver Transplantation M. Muñoz-Navas 1, J. Baillie 2 1 University of Pamplona, Pamplona, Spain [Guest Discussant] 2 Dept. of Medicine, Duke University

More information

[7] Greene, B. S., Loubeau, J. M., Peoples, J. B. and Elliott, D. W. (1991). Are pancreatoenteric anastomoses improved

[7] Greene, B. S., Loubeau, J. M., Peoples, J. B. and Elliott, D. W. (1991). Are pancreatoenteric anastomoses improved 136 HPB INTERNATIONAL mosis. In our experience, roughly 10% of patients will have low volume amylase-rich fluid draining via the drains. Over 85% of these low volume pancreatic fistulas will heal with

More information

NIH Public Access Author Manuscript Surg Clin North Am. Author manuscript; available in PMC 2011 April 29.

NIH Public Access Author Manuscript Surg Clin North Am. Author manuscript; available in PMC 2011 April 29. NIH Public Access Author Manuscript Published in final edited form as: Surg Clin North Am. 1977 April ; 57(2): 361 373. Transplantation of the Liver Charles W. Putnam, M.D. * and Thomas E. Starzl, M.D.,

More information

Outcomes after liver transplantation in accordance with ABO compatibility: A systematic review and meta-analysis

Outcomes after liver transplantation in accordance with ABO compatibility: A systematic review and meta-analysis Submit a Manuscript: http://www.f6publishing.com DOI: 10.3748/wjg.v23.i35.6516 World J Gastroenterol 2017 September 21; 23(35): 6516-6533 ISSN 1007-9327 (print) ISSN 2219-2840 (online) META-ANALYSIS Outcomes

More information

Corporate Medical Policy Liver Transplant and Combined Liver-Kidney Transplant

Corporate Medical Policy Liver Transplant and Combined Liver-Kidney Transplant Corporate Medical Policy Liver Transplant and Combined Liver-Kidney Transplant File Name: Origination: Last CAP Review: Next CAP Review: Last Review: liver_transplant_and_combined_liver_kidney_transplant

More information

Non-infectious hepatic complications in patients with GVHD

Non-infectious hepatic complications in patients with GVHD Non-infectious hepatic complications in patients with GVHD Tapani Ruutu Helsinki University Central Hospital Liver dysfunction in allogeneic stem cell transplantation injury secondary to the cytoreductive

More information

Since the first description of living-donor liver transplantation

Since the first description of living-donor liver transplantation CLINICAL AND TRANSLATIONAL RESEARCH Endoscopic Management of Biliary Complications After Adult Living-Donor Versus Deceased-Donor Liver Transplantation Carlos Macías Gómez, 1,4 Jean-Marc Dumonceau, 2 Mariano

More information

2. Description of the activity

2. Description of the activity Curricular Components for GI EPA 1. EPA Title Care of infants, children and adolescents with acute and chronic liver diseases, biliary/cholestatic diseases, pancreatic disorders, and those requiring liver

More information

EVALUATION OF ABNORMAL LIVER TESTS

EVALUATION OF ABNORMAL LIVER TESTS EVALUATION OF ABNORMAL LIVER TESTS MIA MANABAT DO PGY6 MOA 119 TH ANNUAL SPRING SCIENTIFIC CONVENTION MAY 19, 2018 EVALUATION OF ABNORMAL LIVER TESTS Review of liver enzymes vs liver function tests Clinical

More information

CLINICAL PRESENTATION OF HEPATIC ARTERY THROMBOSIS AFTER LIVER TRANSPLANTATION IN THE CYCLOSPORINE ERA1,2

CLINICAL PRESENTATION OF HEPATIC ARTERY THROMBOSIS AFTER LIVER TRANSPLANTATION IN THE CYCLOSPORINE ERA1,2 41 1337/85/46-667$2./ TRANSPLANTATION Copyright 1985 by The Williams & Wilkins Co. Vol. 4, No.6 Printed in U. S. A. CLINICAL PRESENTATION OF HEPATIC ARTERY THROMBOSIS AFTER LIVER TRANSPLANTATION IN THE

More information

Liver Transplantation

Liver Transplantation Liver Transplantation Dr Mathew Jacob - MRCS FRCS CCT (UK) Lead Consultant HPB/Transplant Surgeon Aster Integrated Liver Care Program AsterMedcity, kochi, kerala, India mathew@transplantationliver.com

More information

Index. Note: Page numbers of article titles are in boldface type.

Index. Note: Page numbers of article titles are in boldface type. Index Note: Page numbers of article titles are in boldface type. A ACLF. See Acute-on-chronic liver failure (ACLF) Acute kidney injury (AKI) in ACLF patients, 967 Acute liver failure (ALF), 957 964 causes

More information

Investigations before OLT, Immunosuppression and rejection, Follow up after OLT.

Investigations before OLT, Immunosuppression and rejection, Follow up after OLT. Investigations before OLT, Immunosuppression and rejection, Follow up after OLT andrea.degottardi@insel.ch When is liver transplantation indicated? When is liver transplantation indicated? Frequent: CIRRHOSIS

More information

Induction Immunosuppression With Rabbit Antithymocyte Globulin in Pediatric Liver Transplantation

Induction Immunosuppression With Rabbit Antithymocyte Globulin in Pediatric Liver Transplantation LIVER TRANSPLANTATION 12:1210-1214, 2006 ORIGINAL ARTICLE Induction Immunosuppression With Rabbit Antithymocyte Globulin in Pediatric Liver Transplantation Ashesh Shah, 1 Avinash Agarwal, 1 Richard Mangus,

More information

A review of histological parameters and CMV serology in Biliary atresia, and its relationship to long-term outcomes

A review of histological parameters and CMV serology in Biliary atresia, and its relationship to long-term outcomes A review of histological parameters and CMV serology in Biliary atresia, and its relationship to long-term outcomes DR A. WITHERS, DR A. GRIEVE DEPARTMENT OF PAEDIATRIC SURGERY UNIVERSITY OF THE WITWATERSRAND

More information

BILIARY TRACT COMPLICATIONS IN HUMAN ORTHOTOPIC LIVER TRANSPLANTATION 1,2

BILIARY TRACT COMPLICATIONS IN HUMAN ORTHOTOPIC LIVER TRANSPLANTATION 1,2 004-33/8/430-004$02.00/0 TRANSPLANTATION Copyright (c) 98 by The Williams & Wilkins Co. Vol. 43, No. Printed in U.S.A. BILIARY TRACT COMPLICATIONS IN HUMAN ORTHOTOPIC LIVER TRANSPLANTATION,2 JAN LERUT,

More information

Aetiology and outcome of neonatal cholestasis in Malaysia

Aetiology and outcome of neonatal cholestasis in Malaysia Original Article Singapore Med J 2010, 51(5) 434 Aetiology and outcome of neonatal cholestasis in Malaysia Lee W S, Chai P F, Boey C M, Looi L M Department of Paediatrics, University of Malaya Medical

More information

UEMS & EBS: DIVISION OF TRANSPLANT SURGERY

UEMS & EBS: DIVISION OF TRANSPLANT SURGERY CURRICULUM AND SYLLABUS TRANSPLANTATION Module 1: Multi-organ retrieval Ability to evaluate donor suitability Ability to retrieve abdominal organs for transplantation Evaluation of donor/ organs suitability

More information

Surgical Management of CBD Injury Jin Seok Heo

Surgical Management of CBD Injury Jin Seok Heo Surgical Management of CBD Injury Jin Seok Heo Department of Surgery, Samsung Medical Center Sungkyunkwan University School of Medicine, Seoul, Republic of Korea Bile duct injury (BDI) Introduction Incidence

More information

Neonatal Cholestasis. What is Cholestasis? Congenital and Pediatric liver diseases 4/26/18

Neonatal Cholestasis. What is Cholestasis? Congenital and Pediatric liver diseases 4/26/18 Congenital and Pediatric liver diseases Nitika Gupta, M.D. Personal/Professional Financial Relationships with Industry in the past year External Industry Relationships * Equity, stock, or options in biomedical

More information

The role of interventional radiology in complications after paediatric liver transplantation

The role of interventional radiology in complications after paediatric liver transplantation The role of interventional radiology in complications after paediatric liver transplantation J Cantrell, M Ch, FCRad (S) Wits onald Gordon Medical Centre, University of the Witwatersrand, Johannesburg,

More information

OPERATIVE TECHNIQUES AND HAZARDS

OPERATIVE TECHNIQUES AND HAZARDS OPERATIVE TECHNIQUES AND HAZARDS CHRIS O SULLIVAN MD FRCSI CONSULTANT HBP AND LIVER TRANSPLANT SURGEON FREEMAN HOSPITAL, N-UPON-TYNE CAVAL RECONSTRUCTION IN ORTHOTOPIC LIVER TRANSPLANTATION RESECTION OF

More information

Liver transplantation: current status, complications and prevention

Liver transplantation: current status, complications and prevention Journal of Antimicrobial Chemotherapy (1995) 36, Suppl. B, 39-49 Liver transplantation: current status, complications and prevention John A. C. Buckels Liver Unit, Queen Elizabeth Hospital, Birmingham

More information

PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS (PFIC)

PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS (PFIC) The Childhood Liver Disease Research Network strives to provide information and support to individuals and families affected by liver disease through its many research programs. PROGRESSIVE FAMILIAL INTRAHEPATIC

More information

Transplant Report Outcomes Report Liver & Intestinal Program

Transplant Report Outcomes Report Liver & Intestinal Program Transplant Report We will always be thankful to everyone on the team at the hospital Davan Jones, liver transplant recipient with parents Leanne and Arica Liver & Intestinal Program: Overview Our Pediatric

More information

Vascular Remodelling in Pancreas Transplantation

Vascular Remodelling in Pancreas Transplantation Vascular Remodelling in Pancreas Transplantation Prof Steve White Consultant HPB/Transplant Surgeon The Freeman Hospital Newcastle President Elect EPITA European Pancreas Transplants Pancreas Transplants

More information

Figure 1. Actuarial survival of patients with ABO I, ABO compatible, and ABO identical grafts.

Figure 1. Actuarial survival of patients with ABO I, ABO compatible, and ABO identical grafts. New Insights into Antibody Mediated Graft Injury after Pediatric Liver Transplantation S.V. McDiarmid MD Professor of Pediatrics and Surgery David Geffen School of Medicine University of California, Los

More information

11 th Banff Conference on Allograft Pathology - An Update

11 th Banff Conference on Allograft Pathology - An Update 11 th Banff Conference on Allograft Pathology - An Update Stefan Hübscher, School of Cancer Sciences, University of Birmingham Dept of Cellular Pathology, Queen Elizabeth Hospital, Birmingham Enghien les

More information

One of the most important problems for patients

One of the most important problems for patients Selection of Donors and Recipients for Living Donor Liver Transplantation Key Points 1. Living donor liver transplantation (LDLT) is increasingly used for adults with end-stage liver disease. 2. Standards

More information

Pediatric Liver Transplantation: small recipient < 10 Kg

Pediatric Liver Transplantation: small recipient < 10 Kg Pediatric Liver Transplantation: small recipient < 10 Kg Introduction The pediatric liver transplant evolved in the 1980s and became established in the 1990s. First successful pediatric liver transplant

More information

D. Debray, Hépatologie pédiatrique Hôpital Bicêtre

D. Debray, Hépatologie pédiatrique Hôpital Bicêtre D. Debray, Hépatologie pédiatrique Hôpital Bicêtre LUNG LIVER GUT AND PORTAL SYSTEM Hepatopulmonary syndrome (HPS) Portopulmonary hypertension (PPH) HEPATOPULMONARY SYNDROME Defect in arterial oxygenation

More information

Simply stated, the major indications for liver transplantation. Indications for Liver Transplantation. Referral for Transplant Evaluation

Simply stated, the major indications for liver transplantation. Indications for Liver Transplantation. Referral for Transplant Evaluation GASTROENTEROLOGY 2008;134:1764 1776 Indications for Liver Transplantation Jacqueline G. O Leary Rita Lepe Gary L. Davis Hepatology, Department of Medicine, Baylor University Medical Center, Dallas, Texas

More information

Endovascular Treatment of Active Bleeding after Liver Transplant

Endovascular Treatment of Active Bleeding after Liver Transplant Endovascular Treatment of Active Bleeding after Liver Transplant Ali Harman, 1 Fatih Boyvat, 1 Baris Hasdogan, 1 Cuneyt Aytekin, 1 Hamdi Karakayali, 2 Mehmet Haberal 2 Objectives: To evaluate the incidence

More information

The authors have declared no conflicts of interest.

The authors have declared no conflicts of interest. Diagnostic Accuracy of Magnetic Resonance Cholangiopancreatography Versus Endoscopic Retrograde Cholangiopancreatography Findings in the Postorthotopic Liver Transplant Population Authors: *Ashok Shiani,

More information

Liver Transplant Pathology a general view

Liver Transplant Pathology a general view Liver Transplant Pathology a general view Dr S E Davies Addenbrooke s Hospital Cambridge University Hospitals NHS Trust ACP/BSG Meeting Leeds 2012 Liver transplantation When and where? Who and why? How?

More information

ORIGINAL ARTICLE. Summary

ORIGINAL ARTICLE. Summary Transplant International ISSN 0934-0874 ORIGINAL ARTICLE Thrombotic and nonthrombotic hepatic artery complications in adults and children following primary liver transplantation with long-term follow-up

More information

Liver Cancer (Hepatocellular Carcinoma or HCC) Overview

Liver Cancer (Hepatocellular Carcinoma or HCC) Overview Liver Cancer (Hepatocellular Carcinoma or HCC) Overview Recent advances in liver cancer care seek to address the rising incidence of liver cancer, which has steadily increased over the past three decades.

More information

Hepatitis C Virus (HCV): Current Screening Guidelines and Treatment Approaches

Hepatitis C Virus (HCV): Current Screening Guidelines and Treatment Approaches Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/medical-breakthroughs-from-penn-medicine/hepatitis-c-virus-hcvcurrent-screening-guidelines-treatment-approaches/9514/

More information

Liver transplantation in mainland China: the overview of CLTR 2011 annual scientific report. Wang, H; Jiang, W; Zhou, Z; Long, J; Li, W; Fan, ST

Liver transplantation in mainland China: the overview of CLTR 2011 annual scientific report. Wang, H; Jiang, W; Zhou, Z; Long, J; Li, W; Fan, ST Title Liver transplantation in mainland China: the overview of CLTR 211 annual scientific report Author(s) Wang, H; Jiang, W; Zhou, Z; Long, J; Li, W; Fan, ST Citation Hepatobiliary Surgery and Nutrition,

More information

Ascites Management. Atif Zaman, MD MPH Oregon Health & Science University Professor of Medicine Division of Gastroenterology and Hepatology

Ascites Management. Atif Zaman, MD MPH Oregon Health & Science University Professor of Medicine Division of Gastroenterology and Hepatology Ascites Management Atif Zaman, MD MPH Oregon Health & Science University Professor of Medicine Division of Gastroenterology and Hepatology Disclosure 1. The speaker Atif Zaman, MD MPH have no relevant

More information

Patient Name: MRN: DOB: Treatment Location:

Patient Name: MRN: DOB: Treatment Location: Page 1 of 5 I. TO (Required) This Section is required to be completed by all patients who undergo kidney transplant surgery. I hereby consent to and authorize Dr. and his/her assistant(s), including supervised

More information

PROGRAMME AT A GLANCE

PROGRAMME AT A GLANCE PROGRAMME AT A GLANCE Hotel Hyatt Andaz Hotel Pullman Date Hall-H1 Hall-H2 Hall-P1 Hall-P2 Hall-P3 Hall-P4 Hall-P5 Hall-P6 Basic science workshop 1 Basic Science Workshop 2 Postgraduate Course - Liver

More information

Results of Choledochojejunostomy in the Treatment of Biliary Complications After Liver Transplantation in the Era of Nonsurgical Therapies

Results of Choledochojejunostomy in the Treatment of Biliary Complications After Liver Transplantation in the Era of Nonsurgical Therapies Results of Choledochojejunostomy in the Treatment of Biliary Complications After Liver Transplantation in the Era of Nonsurgical Therapies Brian R. Davidson, Rakesh Rai, Ashim Nandy, Nilesh Doctor, Andrew

More information

12/13/16. I. Liver transplantation for children and adults (initial or retransplantation) - must satisfy the following: A and B

12/13/16. I. Liver transplantation for children and adults (initial or retransplantation) - must satisfy the following: A and B Reference #: MC/T004 Page: 1 of 8 PRODUCT APPLICATION: PreferredOne Administrative Services, Inc. (PAS) ERISA PreferredOne Administrative Services, Inc. (PAS) Non-ERISA PreferredOne Community Health Plan

More information

Donor Hypernatremia Influences Outcomes Following Pediatric Liver Transplantation

Donor Hypernatremia Influences Outcomes Following Pediatric Liver Transplantation 8 Original Article Donor Hypernatremia Influences Outcomes Following Pediatric Liver Transplantation Neema Kaseje 1 Samuel Lüthold 2 Gilles Mentha 3 Christian Toso 3 Dominique Belli 2 Valérie McLin 2 Barbara

More information

Biliary Atresia. Who is at risk for biliary atresia?

Biliary Atresia. Who is at risk for biliary atresia? Biliary Atresia Biliary atresia is a life-threatening condition in infants in which the bile ducts inside or outside the liver do not have normal openings. Bile ducts in the liver, also called hepatic

More information

Related Policies None

Related Policies None Medical Policy MP 7.03.06 BCBSA Ref. Policy: 7.03.06 Last Review: 08/20/2018 Effective Date: 08/20/2018 Section: Surgery Related Policies None DISCLAIMER Our medical policies are designed for informational

More information

Related Policies: None

Related Policies: None Medical Policy MP 7.03.06 Original Policy Date: December 1995 Last Review: 09/28/2017 Effective Date: 11/15/2017 Section: Surgery End Date: Related Policies: None Disclaimer Our medical policies are designed

More information

Pancreas Transplantation. Sonia Clarke-Swaby Recipient Kidney/pancreas Transplant Co-ordinator Guy s Hospital

Pancreas Transplantation. Sonia Clarke-Swaby Recipient Kidney/pancreas Transplant Co-ordinator Guy s Hospital Pancreas Transplantation Sonia Clarke-Swaby Recipient Kidney/pancreas Transplant Co-ordinator Guy s Hospital Introduction Selection criteria, New innovation Complications, Success rates, Life expectancy

More information